Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNG-IUS vs GnRHa in Infertile Adenomyosis
NCT06581679Completed
- Sponsor
- Zagazig University
- Start
- Dec 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of avatrombopag in adenomyosis and infertility (2 arms), sponsored by Zagazig University. Primary endpoints: Adenomyosis Treatment Efficacy at 6 months, Chemical Pregnancy Rate at 6 months and 1 more. Started Dec 2023; status: completed.
02
Drugs
avatrombopag
03
Conditions
adenomyosisinfertility
Beyond the preview
Go deeper on NCT06581679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06581679.